Anesthetic dosage for hysteroscopic surgery
Conditions
Interventions
Experimental Group:Drug dose adjustment
Sponsors
Jinan Maternal and Child Health Care Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients scheduled to undergo hysteroscopy requiring intravenous anesthesia; 2. ASAI–II; 3.Aged 18–65 years; 4. Body mass index (BMI) of 18–30 kg/m²;
Exclusion criteria
Exclusion criteria: 1. Cardiopulmonary diseases; 2. Alcohol abuse; 3.Hepatic and renal dysfunction; 4.Obstructive sleep apnea-hypopnea syndrome (OSAHS); 5. Long-term use of sedatives, opioids, and antidepressants; 6.Allergy to anesthetic drugs; 7. Difficult cervical dilation, defined as cervical dilation duration > 5 minutes; 8.Surgical duration > 30 minutes;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The initial dose of remimazolam for each patient; | — |
Secondary
| Measure | Time frame |
|---|---|
| Remimazolam dosage;Systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate, blood oxygen saturation;Adverse reactions;Surgical time?Recovery time; | — |
Countries
China
Contacts
Public ContactQingling Ma
Jinan Maternal and Child Health Care Hospital
Outcome results
None listed